The recent choppiness in the electric vehicle (EV) sector may give a fleeting sense of pause, but weakness often paves the path to opportunity. As global...
Many experts have been predicting some big mergers and acquisitions in the psychedelic industry. Well, it looks like they were spot on. This week has...
Its parent company, Otsuka Holdings Co. Ltd., has a market cap hovering above $20 million. The post Otsuka Pharmaceutical to Acquire Mindset Pharma for...
This morning we received news of Mindset Pharma being sold to a big pharma player, Otsuka Pharmaceutical. The post Breaking News: Otsuka Pharmaceutical...
Cybin and Small Pharma holders will own around 74.5% and 25.5% of the combined company, respectively. The post Cybin Acquires Small Pharma in All-Share...
The companies say they will have the most substantial dataset on the DMT molecule in the industry and largest IP portfolio The post Cybin inks agreement...
In big breaking news, Cybin has signed a deal to acquire Small Pharma, giving Cybin an advanced DMT trial. The post Breaking News: Cybin to Acquire...
VANCOUVER, British Columbia, Aug. 25, 2023 (GLOBE NEWSWIRE) — MindBio Therapeutics (CSE:MBIO) (FSE:WF6), an Australia-based... The post InvestmentPitch...
Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing...
If all warrants are exercised, an additional $160 million comes into play. The post Compass Pathways Lands $125M Investment appeared first on Green Market...